TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $184,000 | +0.5% | 10,068 | 0.0% | 0.01% | -25.0% |
| Q4 2020 | $183,000 | +1.7% | 10,068 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $180,000 | -0.6% | 10,068 | 0.0% | 0.01% | -30.0% |
| Q2 2020 | $181,000 | +18.3% | 10,068 | 0.0% | 0.01% | -9.1% |
| Q1 2020 | $153,000 | -23.5% | 10,068 | -0.6% | 0.01% | 0.0% |
| Q4 2019 | $200,000 | -74.6% | 10,133 | -77.8% | 0.01% | -76.1% |
| Q3 2019 | $787,000 | -2.7% | 45,733 | 0.0% | 0.05% | -2.1% |
| Q2 2019 | $809,000 | -98.2% | 45,733 | +4807.0% | 0.05% | -73.9% |
| Q1 2019 | $45,733,000 | – | 932 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 7,584,930 | $138,046,000 | 26.79% |
| Glenview Capital Management | 15,260,512 | $277,741,000 | 6.37% |
| Paulson & Co. | 11,295,846 | $205,584,000 | 5.34% |
| GMT CAPITAL CORP | 2,871,395 | $52,259,000 | 3.72% |
| MANAGED ASSET PORTFOLIOS, LLC | 966,643 | $17,593,000 | 3.09% |
| TFG Asset Management GP Ltd | 1,443,052 | $26,264,000 | 1.76% |
| Mondrian Investment Partners LTD | 3,274,660 | $58,944,000 | 1.46% |
| Blackcrane Capital, LLC | 35,236 | $641,000 | 1.26% |
| Lumbard & Kellner, LLC | 136,378 | $2,404,000 | 0.95% |
| DAVIDSON INVESTMENT ADVISORS | 509,800 | $9,278,000 | 0.86% |